Short Interest in Raia Drogasil S.A. (OTCMKTS:RADLY) Decreases By 53.7%
by Teresa Graham · The Cerbat GemRaia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totaling 478 shares, a decline of 53.7% from the April 30th total of 1,032 shares. Based on an average trading volume of 11,859 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.
Check Out Our Latest Stock Report on RADLY
Raia Drogasil Price Performance
Shares of Raia Drogasil stock traded down $0.03 during trading on Friday, hitting $3.84. 72,541 shares of the company were exchanged, compared to its average volume of 20,602. Raia Drogasil has a 1-year low of $2.17 and a 1-year high of $5.34. The firm’s fifty day moving average price is $4.36 and its 200 day moving average price is $4.52.
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.